Launches Indigo ® System Lightning™ 12 in U.S. Appoints Corey L. Teigen, M.D., as Chief Scientific Officer and James F. Benenati, M.D., FSIR, as Chief Medical ...
ALAMEDA, Calif., Nov. 10, 2020 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced a new partnership to develop solutions to enable ...
SALT LAKE CITY (March 25, 2024)—The Society of Interventional Radiology (SIR) Foundation, The VIVA Foundation and Penumbra, Inc., today announced the launch of the EMBOLIZE trial, a first-of-its-kind ...
The Penumbra 3D Trial successfully met the primary trial endpoints, demonstrating non-inferiority in both safety and efficacy of the company's next-generation stent retriever, Penumbra 3D ...
Penumbra (PEN) on Sunday unveiled results of a "landmark" study that showed its Lightning Flash device is superior to blood thinners, alone, in patients with pulmonary embolism. The results could ...
Penumbra, Inc., a global healthcare company focused on innovative therapies, today announced U.S. commercial availability of the Penumbra System's most advanced technology: Penumbra JET 7 and Penumbra ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Launches Indigo® System Lightning™ 12 in U.S. Appoints Corey L. Teigen, M.D., as Chief Scientific Officer and James F. Benenati, M.D., FSIR, as Chief Medical Officer Lightning™ 12 – Intelligent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results